Table 1 Demographic information and clinical features (n = 72) (mean ± sd)

 Age (yr)

56.2 ± 16.0

 Male (%)

37.5

 Smoker (%)

16.7

 Dialysis vintage (m)

41.2 ± 36.1

 BMI (kg/m²)

22.9 ± 3.6

 Average blood pressure (mmHg)

137.8/77.2 ± 21.6/13.6

 Hypertension (%)

90.3

  Hypertension duration (m, median (range))

95.8 (1.53–658.3);

 Diabetes mellitus (%)

31.9

  DM duration (m, median (range))

165.0 (48.3–462.5)

 Atherosclerosis (%)

18.1

  Atherosclerosis duration (m, median (range))

79.1 (4.2–164.2)

 History of ischemia stroke (%)

5.6

 History of hemorrhagic stroke (%)

1.4

 Undergoing antiplatelet therapy¹(%)

29.2

 Patients on ACEI (%)

13.9

 Patients on ARB (%)

36.1

 Hemoglobin (g/L)

113.9 ± 13.7

 Serum albumin (g/L)

35.4 ± 3.9

 Serum creatinine (umol/L)

858.3 ± 271.1

 Urea nitrogen (mmol/L)

18.0 ± 5.2

 Serum uric acid (umol/L)

369.2 ± 60.0

 Calcium and phosphamid product (mmol²/L²)

3.6 ± 1.0

 Serum TCHO (mmol/L)

4.6 ± 1.0

 Serum TG (mmol/L)

1.9 ± 1.2

 hs CRP (mg/L)

6.4 ± 8.9

 TSAT (%)

29.1 ± 12.0

 iPTH (pg/ml)

359.7 ± 475.1

 β2-MG (mg/L) (n = 66)

35.7 ± 14.1

 Weekly total KT/Vurea^a

2.2 ± 0.7

 nPCR (g/kg/d)^b

0.9 ± 0.25